Improvement of the Firocoxib Dissolution Performance Using Electrospun Fibers Obtained from Different Polymer/Surfactant Associations.

Lauretta Maggi, Valeria Friuli, Enrica Chiesa, Silvia Pisani, Mirena Sakaj, Paolo Celestini, Giovanna Bruni
Author Information
  1. Lauretta Maggi: Department of Drug Sciences, University of Pavia, Via Taramelli 12, 27100 Pavia, Italy. lauretta.maggi@unipv.it.
  2. Valeria Friuli: Department of Drug Sciences, University of Pavia, Via Taramelli 12, 27100 Pavia, Italy. valeria.friuli@unipv.it.
  3. Enrica Chiesa: Department of Drug Sciences, University of Pavia, Via Taramelli 12, 27100 Pavia, Italy. enrica.chiesa01@universitadipavia.it.
  4. Silvia Pisani: Department of Drug Sciences, University of Pavia, Via Taramelli 12, 27100 Pavia, Italy. silvia.pisani01@universitadipavia.it.
  5. Mirena Sakaj: Department of Chemistry, Physical-Chemistry Section, University of Pavia, Via Taramelli 16, 27100 Pavia, Italy. mirena.sakaj01@universitadipavia.it.
  6. Paolo Celestini: Cosma S.P.A., Via Colleoni 15/17, 24040 Ciserano, Italy. p.celestini@cosma.it.
  7. Giovanna Bruni: Department of Chemistry, Physical-Chemistry Section, University of Pavia, Via Taramelli 16, 27100 Pavia, Italy. giovanna.bruni@unipv.it. ORCID

Abstract

An electrospinning process was optimized to produce fibers of micrometric size with different combinations of polymeric and surfactant materials to promote the dissolution rate of an insoluble drug: firocoxib. Scanning Electron Microscopy (SEM) showed that only some combinations of the proposed carrier systems allowed the production of suitable fibers and further fine optimization of the technique is also needed to load the drug. Differential scanning calorimetry (DSC) and X-ray powder diffraction (XRPD) suggest that the drug is in an amorphous state in the final product. Drug amorphization, the fine dispersion of the active in the carriers, and the large surface area exposed to water interaction obtained through the electrospinning process can explain the remarkable improvement in the dissolution performance of firocoxib from the final product developed.

Keywords

References

  1. J Physiol. 1975 Mar;246(2):289-309 [PMID: 1142245]
  2. Vet Ther. 2006 Summer;7(2):127-40 [PMID: 16871495]
  3. Vet Rec. 2006 Oct 21;159(17):547-51 [PMID: 17056650]
  4. Vet Rec. 2010 Feb 20;166(8):226-30 [PMID: 20173106]
  5. J Vet Pharmacol Ther. 2011 Apr;34(2):190-2 [PMID: 21395612]
  6. Vet Rec. 2011 Jun 11;168(23):617 [PMID: 21642297]
  7. Int J Pharm. 2013 Aug 30;453(1):3-11 [PMID: 23124107]
  8. J Control Release. 2014 Jul 10;185:12-21 [PMID: 24768792]
  9. J Pharm Sci. 2015 Nov;104(11):3798-803 [PMID: 26183222]
  10. AAPS PharmSciTech. 2016 Feb;17(1):106-19 [PMID: 26335416]
  11. AAPS PharmSciTech. 2016 Feb;17(1):148-57 [PMID: 26511936]
  12. Int J Pharm. 2016 Sep 10;511(1):190-197 [PMID: 27418562]

MeSH Term

4-Butyrolactone
Cyclooxygenase 2 Inhibitors
Drug Carriers
Nanofibers
Polymers
Solubility
Spectroscopy, Fourier Transform Infrared
Sulfones
Surface-Active Agents
Thermodynamics

Chemicals

Cyclooxygenase 2 Inhibitors
Drug Carriers
Polymers
Sulfones
Surface-Active Agents
4-Butyrolactone
firocoxib

Word Cloud

Created with Highcharts 10.0.0drugelectrospinningfibersdissolutionprocesscombinationspolymericsurfactantratefirocoxibfinefinalproductoptimizedproducemicrometricsizedifferentmaterialspromoteinsolubledrug:ScanningElectronMicroscopySEMshowedproposedcarriersystemsallowedproductionsuitableoptimizationtechniquealsoneededloadDifferentialscanningcalorimetryDSCX-raypowderdiffractionXRPDsuggestamorphousstateDrugamorphizationdispersionactivecarrierslargesurfaceareaexposedwaterinteractionobtainedcanexplainremarkableimprovementperformancedevelopedImprovementFirocoxibDissolutionPerformanceUsingElectrospunFibersObtainedDifferentPolymer/SurfactantAssociationspoorlysolubleveterinary

Similar Articles

Cited By